Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.1/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Even with readOnly/openWorld/idempotent annotations present, the description adds substantial behavioral context: it fans out across multiple external sources, exposes sources_used/sources_failed, clarifies that an empty section means 'no data, not a bug', and explains private-company behavior with resolved:false and a notes line. It also sets expectations for fda_products when a company has no biologic products.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness2/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description front-loads examples and the key 'ALWAYS PREFER' guidance, but it contains a garbled, malformed middle section — e.g., 'fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted?); (weird string: patents (USPTO patents); ...' — which reads as corrupted text and harms scannability. It is also much longer than needed without clean sectioning.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with no output schema, the description covers a great deal: accepted input forms, source fan-out, main output fields, maximum filings count, resolved:false behavior, and empty-section semantics. The garbled middle section slightly obscures the exact list of returned blocks, so it is not a flawless 5.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Input schema coverage is 100%, and both parameter descriptions already explain accepted forms and interchangeability. The description reinforces this with concrete examples and a private-company edge case, but it does not add substantial new parameter semantics beyond what the schema already documents.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific, high-value action: producing a 'full cross-source profile of a US public company in ONE parallel call.' It is packed with example queries ('research Acme', 'brief me on Tesla') and clearly distinguishes itself from 'chaining single-pack SEC/XBRL/news lookups.'

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says to 'ALWAYS PREFER' this tool over chaining single-pack lookups when the user asks for a holistic view, naming the alternative category explicitly. It does not give a crisp 'when not to use' or route to sibling tools like resolve_entity or deep_research, so it stops just short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Many tools have overlapping purposes, especially in the prediction market domain (e.g., bet_research, polymarket_edges, polymarket_arbitrage, polymarket_fill_risk) and data querying (ask_pipeworx, ask_pipeworx_grounded, deep_research). This overlap creates confusion for an agent selecting the right tool.

Naming Consistency2/5

Naming is inconsistent: most tools use snake_case but some start with a verb (ask_, bet_, compare_) while others start with a noun (entity_profile, pipeworx_feedback, polymarket_*). There is no uniform pattern, making it harder to predict tool names.

Tool Count2/5

With 32 tools, the server is overstuffed for a single focus. It bundles checksums, AI visibility, data queries, prediction market analysis, subscriptions, memory, and more, which would be better split into separate, more focused servers.

Completeness2/5

Despite the large tool count, the server lacks completeness in key areas: no tool to place prediction market trades, no direct SEC filing detail extraction (only through generic queries), and only two checksum tools despite the server name 'Crc'. The surface feels scattershot rather than comprehensive.